Influenza A virus H5N1 vaccine - Medicago

Drug Profile

Influenza A virus H5N1 vaccine - Medicago

Alternative Names: H5N1 avian influenza virus-like particle (VLP) vaccine - Medicago; H5N1 VLP vaccine - Medicago; MT-8972; One-dose H5N1 VLP vaccine - Medicago; Pandemic flu vaccine - Medicago; Plant-derived influenza vaccines - Medicago; Plant-made H5 VLP influenza vaccine - Medicago

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Medicago
  • Developer Infectious Disease Research Institute; Medicago
  • Class Influenza A virus H5N1 vaccines; Viral vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Influenza A virus H5N1 subtype

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype(Prevention, In volunteers) in USA (IM, Injection)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype(Prevention, In volunteers) in USA (Intradermal, Injection)
  • 01 Jan 2014 Infectious Disease Research Institute completes a phase I trial for Influenza-A virus H5N1 subtype (prevention, in volunteers) in USA (SC or Intradermal) (NCT01657929)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top